If you would like to ask our webinar guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.
Allenby briefing note last year said they’d only earn $300k from this contract as it had been moving slower. RNS suggests they’ve received more than the full amount now for the existing contract which should be a good boost for 23/24. They’re also entitled to royalty and milestones from this contract.
Very interesting presentation. First time he did a dummies guide, clearly very passionate about the science. CEO also more than happy being paid in shares and buying them and is baffled by low market cap.
It won’t be long until the good news comes!!
CEO was talking about very significant connections made at Antibody conference before Christmas in his presentation.
It’s nice it’s starting to tick up without the ramp and pump and dump brigade around too 😂
Agreed. Their CFO committed to update the market if there was a material change from their projections (which are no need to fundraise if they meet h2 targets which they were on track to do so in December) so in a way hopefully no news is good news.
I would anticipate we would get something this month hopefully anyway given they did commit to more frequent updates.
This is the acquisition . As of 2023 I believe it was publishers that fusion have royalty interests in 9 projects and a further financial interest in 4 which provide fixed milestone payments. If any or multiple of those are acquired or come to fruition then big payouts also, separately to the great prigesss being made on optimal and aimlab.
https://www.b3cnewswire.com/202401082504/calypso-enters-into-agreement-to-be-acquired-by-novartis.html
Expecting rally heading towards 8-9p
https://x.com/zakstraderscafe/status/1747561915759403438?s=46